| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/17/2011 | CA2772748A1 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof |
| 03/17/2011 | CA2772656A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units |
| 03/17/2011 | CA2772069A1 Osteolysis treatment |
| 03/17/2011 | CA2771863A1 Compositions that induce t cell help |
| 03/16/2011 | EP2295577A2 Human cytokine as ligand of the z-alpha receptor and uses thereof |
| 03/16/2011 | EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 03/16/2011 | EP2295575A2 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 03/16/2011 | EP2295568A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 03/16/2011 | EP2295560A1 Directed evolution of arginine deiminase for increased activity at physiological pH |
| 03/16/2011 | EP2295552A2 Mutations in OAS1 genes |
| 03/16/2011 | EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 03/16/2011 | EP2295464A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295463A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295462A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295461A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295460A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295459A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295458A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295457A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295453A2 An appetite-suppressing peptide, its compositions and use |
| 03/16/2011 | EP2295452A1 Glucagon-like-peptide-2 (GLP-2) analogues |
| 03/16/2011 | EP2295451A1 Glucagon-like-peptide (GLP-2) analogues |
| 03/16/2011 | EP2295449A1 PLGF-1 in homodimeric form |
| 03/16/2011 | EP2295448A1 Sclerostin epitopes |
| 03/16/2011 | EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/16/2011 | EP2295444A2 Lipopeptides as antibacterial agents |
| 03/16/2011 | EP2295443A1 Tumor-associated peptides which bind to MHC molecules |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295082A1 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 03/16/2011 | EP2295081A1 Antibodies to OPGL |
| 03/16/2011 | EP2295079A2 Method for treating inflammation |
| 03/16/2011 | EP2295078A2 Method for treating inflammation |
| 03/16/2011 | EP2295074A1 Anti-neovasculature preparations for treating cancer |
| 03/16/2011 | EP2295072A1 Use of ARC for inhibiting cell death during liver failure |
| 03/16/2011 | EP2295071A1 Low dose methods for treating disorders in which TNF-alpha activity is detrimental |
| 03/16/2011 | EP2295070A1 Use of VEGF and homologues to treat neuron disorders |
| 03/16/2011 | EP2295069A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/16/2011 | EP2295068A1 Modified agrin-fragment capable of restoring muscle strength for use as a medicament |
| 03/16/2011 | EP2295067A1 E-selectin for inducing immunotolerance |
| 03/16/2011 | EP2295066A1 Peptides, derivatives and analogs thereof, and methods of using same |
| 03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
| 03/16/2011 | EP2295064A1 Monoclonal antibody therapy for pancreas cancer |
| 03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295056A1 Use of SNS-595 for treating leukemia |
| 03/16/2011 | EP2295052A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450 |
| 03/16/2011 | EP2295039A1 Pancreatin pellets, in particular pancreatin micropellets and method for producing same |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294416A1 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 03/16/2011 | EP2294197A2 Variant hhip1 protein and methods and uses thereof |
| 03/16/2011 | EP2294189A2 The large form of human 2', 5'-oligoadenylate synthetase oas3 for preventing or treating infection with positive-sense single-stranded rna viruses |
| 03/16/2011 | EP2294180A1 Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island |
| 03/16/2011 | EP2294087A1 Anti-hepcidin antibodies and methods of use |
| 03/16/2011 | EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 03/16/2011 | EP2294081A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 03/16/2011 | EP2293811A1 Derivatised hybrid peptides of amylin and salmon calcitonin |
| 03/16/2011 | EP2293810A2 Compositions and methods for preventing or treating aids |
| 03/16/2011 | EP2293809A2 Peptidyl diacylglycerides |
| 03/16/2011 | EP2293808A1 An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| 03/16/2011 | EP2293807A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 03/16/2011 | EP2293785A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 03/16/2011 | EP2293678A1 Angiogenin-enriched milk fractions |
| 03/16/2011 | EP2219665B1 Parathyroid hormone formulations and uses thereof |
| 03/16/2011 | EP2173890B1 Biological active proteins having increased in vivo and/or vitro stability |
| 03/16/2011 | EP2118137B1 Peptides and polypeptides with improved stability useful in the regeneration of the nervous system |
| 03/16/2011 | EP1978026B1 T-helper antigenic determinant (thd) peptides |
| 03/16/2011 | EP1943267B1 A process for the preparation of perindopril erbumine |
| 03/16/2011 | EP1912661B1 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation |
| 03/16/2011 | EP1843746B1 Somatostatin analogue formulations |
| 03/16/2011 | EP1812046B1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 03/16/2011 | EP1641926B1 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 03/16/2011 | EP1631266B1 A method of treating degenerative disc disease |
| 03/16/2011 | EP1436320B1 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 03/16/2011 | EP1420762B1 Residual solvant extraction method and microparticles produced thereby |
| 03/16/2011 | EP1420010B1 Amphoteric lipid compound and use thereof |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | EP1383785B1 Recombinant tumor specific antibody and use thereof |
| 03/16/2011 | EP1248796B1 Process for the purification of antithrombin-iii |
| 03/16/2011 | CN101985644A Momordica charantia polypeptide, preparation method and application thereof |
| 03/16/2011 | CN101985625A Issatchenkia terricola acetaldehyde dehydrogenase gene and expression vector thereof |
| 03/16/2011 | CN101985478A Fusion protein and application thereof to ischemic brain stroke |
| 03/16/2011 | CN101985470A Glucagon-like polypeptide-1 analog, preparation method and application thereof |
| 03/16/2011 | CN101985469A Ruditapes philippinarum big defensin and preparation method and application thereof |
| 03/16/2011 | CN101985468A SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 03/16/2011 | CN101985467A Analgesic active peptide VGG and preparation method and applications thereof |
| 03/16/2011 | CN101985464A High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 03/16/2011 | CN101985036A Amyloid- beta (1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 03/16/2011 | CN101985035A Perindopril-containing compound preparation for treating hypertension |
| 03/16/2011 | CN101985034A Application of soy peptide |
| 03/16/2011 | CN101984979A Disease toxin expelling juice |
| 03/16/2011 | CN101407815B Use of glycine-N-methyltransferase (GNMT) in preparing medicine for preventing and treating disease derived from flavacin |
| 03/16/2011 | CN101381403B Alpha type conotoxin peptide derivates and use thereof |
| 03/16/2011 | CN101081212B Protease inhibitors liposomes aerosol |
| 03/15/2011 | US7906641 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |
| 03/15/2011 | US7906636 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 03/15/2011 | US7906634 HEMCM42 nucleic acids |
| 03/15/2011 | US7906630 Method for identifying peptides in a biological sample |
| 03/15/2011 | US7906628 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 03/15/2011 | US7906626 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |